Oncoinvent ASA Capital Reinvestment Ratio
Oncoinvent ASA capital reinvestment ratio. Oncoinvent ASA (KLDVK) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Nkr3.64 Million) in capital expenditures (Nkr2.12 Million). See Oncoinvent ASA (KLDVK) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oncoinvent ASA (2021–2022)
Capital reinvestment ratio of Oncoinvent ASA from 2021 to 2022. This chart tracks Oncoinvent ASA's Capital Reinvestment Ratio across 2 annual periods. See how financially flexible is Oncoinvent ASA to measure the company's free cash flow as a share of total liabilities.
Oncoinvent ASA Capital Reinvestment Ratio by Year (2021–2022)
Oncoinvent ASA capital reinvestment ratio by year from 2021 to 2022. For the full cash flow conversion analysis, see Oncoinvent ASA cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 32.49x | Nkr373.06K | Nkr12.12 Million | ▼ -86.3% |
| 2021 | 236.36x | Nkr130.66K | Nkr30.88 Million | — |